Zobrazeno 21 - 30
of 672
pro vyhledávání: '"Emanuele Zucca"'
Autor:
Annarita Conconi, Catherine Thieblemont, Luciano Cascione, Valter Torri, Barbara Kiesewetter, Gloria Margiotta Casaluci, Gianluca Gaidano, Markus Raderer, Franco Cavalli, Armando Lopez Guillermo, Peter W. Johnson, Emanuele Zucca
Publikováno v:
Haematologica, Vol 105, Iss 11 (2020)
Early progression of disease (POD) within two years from diagnosis is linked with poor overall survival (OS) in follicular lymphoma but its prognostic role is less clear in extranodal marginal zone B-cell lymphoma (EMZL). We sought to identify progno
Externí odkaz:
https://doaj.org/article/cd61212d0902410ba5cedd840be22974
Autor:
Luciano Cascione, Andrea Rinaldi, Alessio Bruscaggin, Chiara Tarantelli, Alberto J. Arribas, Ivo Kwee, Lorenza Pecciarini, Afua A. Mensah, Valeria Spina, Elaine Y.L. Chung, Lodovico Terzi di Bergamo, Stephan Dirnhofer, Alexandar Tzankov, Roberto N. Miranda, Ken H. Young, Alexandra Traverse-Glehen, Gianluca Gaidano, Steven H. Swerdlow, Randy Gascoyne, Raul Rabadan, Maurilio Ponzoni, Govind Bhagat, Davide Rossi, Emanuele Zucca, Francesco Bertoni
Publikováno v:
Haematologica, Vol 104, Iss 12 (2019)
Externí odkaz:
https://doaj.org/article/0dd09524151d43fca254706ac775bfa2
Autor:
Stuart W. Hicks, Chiara Tarantelli, Alan Wilhem, Eugenio Gaudio, Min Li, Alberto J. Arribas, Filippo Spriano, Roberta Bordone, Luciano Cascione, Katharine C. Lai, Qifeng Qiu, Monica Taborelli, Davide Rossi, Georg Stussi, Emanuele Zucca, Anastasios Stathis, Callum M. Sloss, Francesco Bertoni
Publikováno v:
Haematologica, Vol 104, Iss 8 (2019)
Antibody-drug conjugates (ADC) are a novel way to deliver potent cytotoxic compounds to cells expressing a specific antigen. Four ADC targeting CD19, including SAR3419 (coltuximab ravtansine), have entered clinical development. Here, we present huB4-
Externí odkaz:
https://doaj.org/article/1f3dab50ef484dd68bae9787aaa3453e
Autor:
Chiara Tarantelli, Lu Zhang, Elisabetta Curti, Eugenio Gaudio, Filippo Spriano, Valdemar Priebe, Luciano Cascione, Alberto J. Arribas, Emanuele Zucca, Davide Rossi, Anastasios Stathis, Francesco Bertoni
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
Externí odkaz:
https://doaj.org/article/8526ea6b4eb945fb95e64418e3fabfdb
Autor:
Afua A. Mensah, Luciano Cascione, Eugenio Gaudio, Chiara Tarantelli, Riccardo Bomben, Elena Bernasconi, Domenico Zito, Andrea Lampis, Jens C. Hahne, Andrea Rinaldi, Anastasios Stathis, Emanuele Zucca, Ivo Kwee, Valter Gattei, Nicola Valeri, Maria E Riveiro, Francesco Bertoni
Publikováno v:
Haematologica, Vol 103, Iss 12 (2018)
Aberrant changes in microRNA expression contribute to lymphomagenesis. Bromodomain and extra-terminal domain inhibitors such as OTX015 (MK-8628, birabresib) have demonstrated preclinical and clinical activity in hematologic tumors. MicroRNA profiling
Externí odkaz:
https://doaj.org/article/767eecafe8b84735906b647d8c4d4c51
Autor:
Valdemar Priebe, Giulio Sartori, Sara Napoli, Elaine Yee Lin Chung, Luciano Cascione, Ivo Kwee, Alberto Jesus Arribas, Afua Adjeiwaa Mensah, Andrea Rinaldi, Maurilio Ponzoni, Emanuele Zucca, Davide Rossi, Dimitar Efremov, Georg Lenz, Margot Thome, Francesco Bertoni
Publikováno v:
Cancers, Vol 12, Iss 7, p 1912 (2020)
Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B cell (GCB) DLBCL and activated-like B cell (ABC) DLBCL, based on transcriptome expressi
Externí odkaz:
https://doaj.org/article/0ca635d1c9f5418395e644c03401ced7
Autor:
Bernhard Gerber, Martina Manzoni, Valeria Spina, Alessio Bruscaggin, Marta Lionetti, Sonia Fabris, Marzia Barbieri, Gabriella Ciceri, Alessandra Pompa, Gabriela Forestieri, Erika Lerch, Paolo Servida, Francesco Bertoni, Emanuele Zucca, Michele Ghielmini, Agostino Cortelezzi, Franco Cavalli, Georg Stussi, Luca Baldini, Davide Rossi, Antonino Neri
Publikováno v:
Haematologica, Vol 103, Iss 6 (2018)
Externí odkaz:
https://doaj.org/article/cac49ae32fee42aa814cbe7b70af622f
Publikováno v:
F1000Research, Vol 7 (2018)
There are three different marginal zone lymphomas (MZLs): the extranodal MZL of mucosa-associated lymphoid tissue (MALT) type (MALT lymphoma), the splenic MZL, and the nodal MZL. The three MZLs share common lesions and deregulated pathways but also p
Externí odkaz:
https://doaj.org/article/2d9ffd2e5a1141338922126c136d217f
Autor:
Dominique Bron, Igor Aurer, Marc P. E. André, Christophe Bonnet, Dolores Caballero, Claire Falandry, Eva Kimby, Pierre Soubeyran, Emanuele Zucca, Andre Bosly, Bertrand Coiffier
Publikováno v:
Haematologica, Vol 102, Iss 6 (2017)
Externí odkaz:
https://doaj.org/article/8a0d4731892b47a0ad11972769fa4f97
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 8, Iss 0, Pp e2016062-e2016062 (2016)
The natural history of follicular lymphoma is usually characterized by an indolent course with a high response rate to the first line therapy followed by recurrent relapses, with a time to next treatment becoming shorter after each subsequent treatme
Externí odkaz:
https://doaj.org/article/732860f82c7e4ee78973c62b54825d6b